TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 1 of 8 ASSESSMENT 2 BRIEFSubject Code and TitleTUM202 Therapeutic use of MedicinesAssessmentCase Study- PolypharmacyIndividual/GroupIndividualLength1500 words (+/- 10%)Learning OutcomesThe Subject Learning Outcomes demonstrated by successfulcompletion of the task below include:a) Identify and discuss the general principles of pharmacologyincluding pharmacokinetic concepts and pharmacodynamics andtheir application to pathophysiological states. (Criteria 1.1, 1.4, 3.2)b) Explain and apply quality & safety frameworks to the use oftherapeutic medicines in clinical practice (Criteria 1.1, 2.7, 2.9, 4.3,6.1, 6.5)c) Compare and contrast the mechanisms of action, therapeuticuses, adverse effects, interactions, contraindications and routes ofadministration of different drug groups. (Criteria 1.1, 4.2)d) Deduce the factors contributing to individual variability anddetermine dosage individualisation strategies to control variabilityin drug response including lifespan aspects of drug therapy andpopulation groups with specific needs. (Criteria 1.1, 4.1, 4.2, 5.1, 6.1,7.1)e) Identify and justify utilisation of evidence‐based referenceresources relating to integrative pharmacology to identify, preventand clinically manage polypharmacy, potential adverse drugreactions, interactions and toxicity to ensure safe practices. (Criteria1.1, 4.1, 4.2, 5.1, 6.1, 7.1)g) Explore and apply professional, legal and ethical issuessurrounding the safe prescription and administration ofmedications. (Criteria 1.1, 1.4, 1.5, 3.4, 5.1,6.2, 6.5, 6.6)SubmissionDue by 11:55pm AEST/AEDT Sunday end of Module 4.2 (week 8)Weighting35%Total Marks100 marks TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 2 of 8Assessment TaskIn this assessment, you will review the case of a patient who is on multiple medications and answer aseries of short answer questions related to polypharmacy (1500 words).Please refer to the Task Instructions for details on how to complete this task.ContextPolypharmacy is a significant problem in the community, particularly for people living with multiplecomorbidities or multiple chronic diseases. Knowledge of medications and their actions andinteractions with each other is an important skill of nursing practice. Drug-drug interactions can havesignificant consequences for the patient. This task is designed to assess the theoretical knowledgethat you have acquired whilst undertaking TUM202 Therapeutic Use of Medicines.InstructionsTo complete this assessment task, you must:1. Read the case study document found in Assessment 2 resources folder on Blackboard.2. Using credible evidence based literature, write a response to the case study that addressesthe following points:• Briefly introduce the case study scenario, and intention of the case study response.• Define polypharmacy.o Explain who is at risk of polypharmacy and why.o Identify and describe the impacts of polypharmacy on 1) the older person, and 2)the healthcare system.• Identify the drug- drug interaction(s) and explain which of the drug -drug interaction(s) arelinked to the signs and symptoms that the case study patient is experiencing.• Explain what is causing the symptoms the patient is experiencing (consider if this is due topathology or a result of the drug interactions and/or human error)• Propose strategies that can be implemented to identify and prevent polypharmacy.• Identify evidence-based resources that can assist the Registered Nurse (RN) to identifypossible drug – drug interactions.• Consider and explain how the RN can incorporate a person centred approach whenadvocating for the case study patient, with relevant members of the multi-disciplinary team.TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 3 of 8Assessment format• A cover page must be included which includes; subject name and code, assessment number,student name, student number and word count• Assessments must be submitted in a Microsoft Word document (unprotected) and not PDF• Headings and Sub-headings should be used for different sections• Size 11 font• Times New Roman or Calibri Body writing style• Double line spacing is requiredReferencingIt is essential that you use appropriate APA style for citing and referencing research. Please see moreinformation on referencing in the Academic Skills webpage.Submission InstructionsPlease submit your word document into the Assessment 2 submission link in the Assessment sectionfound in the main navigation menu of the subject TUM202 Blackboard site. A rubric will be attachedto the assessment. The Learning Facilitator will provide feedback via the Grade Centre in the LMSportal. Feedback can be viewed in My Grades. Assessments must be submitted in a Microsoft Worddocument (unprotected) and not PDFAcademic IntegrityAll students are responsible for ensuring that all work submitted is their own and is appropriatelyreferenced and academically written according to the Academic Writing Guide. Students also needto have read and be aware of Torrens University Australia Academic Integrity Policy and Procedureand subsequent penalties for academic misconduct. These are viewable online.Students also must keep a copy of all submitted material and any assessment drafts.TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 4 of 8Assessment Rubric AssessmentAttributesFail(Yet to achieveminimum standard)0-49%Pass(Functional)50-64%Credit(Proficient)65-74%Distinction(Advanced)75-84%High Distinction(Exceptional)85-100%Knowledge andunderstanding ofpolypharmacy and itsimplications for thepatient andhealthcare system15%Incomplete knowledgeand understanding ofpolypharmacy.Omitted or inaccuratedefinition ofpolypharmacy.Does not accuratelyexplain the impacts ofpolypharmacy on thepatient or healthcaresystem.Demonstrates basicknowledge andunderstanding ofpolypharmacy.Limited definition ofpolypharmacy, no-minimalkey elements ofpolypharmacy identified.Basic attempt to explain theimpacts of polypharmacy onthe patient or healthcaresystem, with key elementsmissing.Demonstrates proficientknowledge andunderstanding ofpolypharmacy.Provides a satisfactorydefinition of polypharmacybut missing multiple keyelements.Satisfactorily explains theimpacts of polypharmacyon the patient or healthcaresystem, with one-two keyelements omitted.Demonstrates strongknowledge andunderstanding ofpolypharmacy.Provides a thoroughdefinition of polypharmacybut missing one or two keyelements.Demonstrates advancedexplanation of the impactsof polypharmacy on thepatient or healthcaresystem.Demonstrates exceptionalknowledge andunderstanding ofpolypharmacy.Provides an exceptionaland accurate definition ofpolypharmacy.Provides an excellentdescription on the impactsof polypharmacy on apatient and healthcaresystem.Identification ofdrug-druginteraction(s) andtheir link to signs andsymptomsexperienced by thecase study patient20%Failure to identify anydrug-drug interaction(s).Unable to identify whichdrug – drug interactionsare causing the patientssymptoms.No-limited use ofevidence based resourcesPartial identification of thedrug – drug interaction(s).Attempts to link druginteractions to signs andsymptoms in the case study.Limited use of evidencebased resources to identifydrug interactions.Identifies drug – druginteraction(s), with keydetail missing.Satisfactory linking of thesigns and symptoms to thedrug interactions.Good use of evidence basedresources to identify druginteractions.Identifies drug- druginteraction(s) with minoromission of relevant details.Well-developed explanationof the link to signs andsymptoms and the drugdrug interactions.Clearly identifies the drug –drug interaction(s).Clearly links the signs andsymptoms to the druginteraction.Exceptional use of evidencebased resources to identifydrug interactions. TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 5 of 8 to identify druginteractions.Very good use of evidencebased resources to identifydrug interactions.Proposal ofstrategies to identifyand preventpolypharmacy,including evidencebased resources15%Limited identification ofstrategies and resourcesto identify and preventpolypharmacyNo- very limitedidentification of evidencebased resources toidentify and preventpolypharma.cyLimited identification ofstrategies and resources toidentify and preventpolypharmacyNo- very limited identificationof evidence based resourcesto identify and preventpolypharmacy.Limited identification ofstrategies and resources toidentify and preventpolypharmacyGood attempt to identifyevidence based resourcesto identify and preventpolypharmacy, with severalkey resources missing.Limited identification ofstrategies and resources toidentify and preventpolypharmacyVery Good identification ofmultiple evidence basedresources to identify andprevent polypharmacy, withone-two key resourcesmissing.Limited identification ofstrategies and resources toidentify and preventpolypharmacyHighly developed, thoroughidentification of multipleevidence based resourcesto identify and preventpolypharmacy.Consideration andexplanation ofincorporation of aperson centredapproach to care,demonstratingadvocacy for the casestudy patient, withrelevant members ofthe multi-disciplinaryteam10%Limited- no explanation ofhow to incorporateperson centredapproaches to care for thecase study patient.Limited ability to identifystrategies to prevent polypharmacy and how thenurse may advocate forpatients.Basic explanation of how toincorporate person centredapproaches to care for thecase study patient, missingkey details and rigor.Some ability to identifystrategies to prevent polypharmacy by advocating forthe patient with members ofthe multi-disciplinary team,but key members and detailsmissingGood explanation of how toincorporate person centredapproaches to care for thecase study patient, withsome key details missing.Identifies several strategiesto prevent polypharmacyby advocating for thepatient with the multidisciplinary team, withsome key strategies andmembers missing.Very good explanation ofhow to incorporate personcentred approaches to carefor the case study patient,with one- two key detailsmissing.Identification of multiplestrategies to preventpolypharmacy, byadvocating for the patientwith the multi-disciplinaryteam, with one-two keystrategies missingExcellent explanation ofhow to incorporate personcentred approaches to carefor the case study patient.Excellent identification ofstrategies to preventpolypharmacy byadvocating for the patientwith the multi-disciplinaryteam.Analysis andapplication withsynthesis of newLimited synthesis andanalysis of topic.Confuses logic andemotion. InformationFunctional synthesis andanalysis of topic.Often conflates/confusesassertion of personal opinionWell-developed analysisand synthesis of the topic.Thoroughly developed andcreative analysis andsynthesis of the topic.Highly developed andcritical analysis, of theinformation pertaining tothe topic. TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 6 of 8 knowledge and linksto case scenario10%taken from reliablesources but without acoherent analysis orsynthesis.Viewpoints of experts aretaken as fact with littlequestioning, or linking tocase study.Limited understanding ofkey concepts required tosupport the case study.with informationsubstantiated by evidencefrom the research/coursematerials.Analysis and evaluation donot reflect expert judgement,intellectual independence,rigor and adaptability.Resembles a recall orsummary of key ideas, withsome links to the case study.Demonstrates a capacity toexplain and apply relevantconcepts.Identifies logical flaws.Questions viewpoints ofexperts, and makes severallinks to the case study.Supports personal opinionand informationsubstantiated by evidencefrom the research/coursematerials.Well demonstrated capacityto explain and applyrelevant concepts, linkingliterature to the case study.Viewpoint of experts aresubject to questioning.Analysis and evaluationreflect growing judgement,intellectual independence,rigor and adaptability.Discriminates betweenassertion of personalopinion and informationsubstantiated by robustevidence from theresearch/course materialsand extended reading.Information is taken fromsources with a high level ofinterpretation/evaluationto develop acomprehensive criticalanalysis or synthesis.Strong links made betweenliterature and the casestudy.Identifies gaps inknowledge.Exhibits intellectualindependence, rigor, goodjudgement andadaptability.Systematically and criticallydiscriminates betweenassertion of personalopinion and informationsubstantiated by robustevidence from theresearch/course materialsand extended readingBreadth and depth ofresearch and the useof resources10%Demonstratesinconsistent use of goodquality, credible andrelevant resources toDemonstrates use of somecredible and relevantresources to support anddevelop ideas.Demonstrates use ofseveral credible resourcesto support and developideas.Demonstrates use ofmultiple good quality,credible and relevantresources to support andDemonstrates use ofmultiple high quality,credible and relevantresources to support anddevelop ideas. TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 7 of 8 support and developideas.Minimal evidence of widescope within the organisationfor sourcing evidenceShows some evidence ofwide scope within theorganisation for sourcingevidence.develop arguments andstatements.Show evidence of widescope within theorganisation for sourcingevidence.Show strong evidence ofwide scope within theorganisation for sourcingevidenceEffectiveCommunication(written)10%Poor presentation ofinformation that does notadhere to the givenformat.Omission of specialisedlanguage and terminologywith accuracyMeaning is repeatedlyobscured by errors in thecommunication andarticulation of ideas,including errors instructure, sequence,spelling, grammar andpunctuation.Under/over word countby more than 10%.Communicates in a readablemanner that largely adheresto the given format.Generally employs specialisedlanguage and terminologywith accuracy.Meaning is sometimesdifficult to follow.Information, arguments andevidence are structured andsequenced in a way that isnot always clear and logical,including minimal use of subheadings.Some errors are evident inspelling, grammar and/orpunctuation.Under/over word count bymore than 10%.Communicates in acoherent and readablemanner that adheres to thegiven format.Accurately employsspecialised language andterminology.Meaning is easy to follow.Information, arguments andevidence are structured andsequenced in a way that isclear and logical.Occasional minor errorspresent in spelling,grammar and/orpunctuation.Within word limit.Communicates coherentlyand concisely in a mannerthat adheres to the givenformat.Accurately employs a widerange of specialisedlanguage and terminology.Engages audience interest.Information, arguments andevidence are structured andsequenced in a way that is,clear and persuasive.Spelling, grammar andpunctuation contain onetwo minor errors.Within word limit.Communicates eloquently.Expresses meaningcoherently, concisely andcreatively within the givenformat.Discerningly selects andprecisely employs a widerange of specialisedlanguage and terminology.Engages and sustainsaudience’s interest.Information, argumentsand evidence are insightful,persuasive and expertlypresented.Spelling, grammar andpunctuation are free fromerrors.Within word limit.Correct citation ofresourcesReferencing is omitted ordoes not resemblerequired APA format.Referencing resemblesrequired APA format, withfrequent or repeated errors.Referencing resemblesrequired APA format, withoccasional errors.APA referencing followsrequired format, containingonly a few minor errors.APA referencing followsrequired format, and is freefrom errors. TUM202_Assessment_2_Brief_Case Study Module Due 4.2 Page 8 of 8 10%The following Subject Learning Outcomes are addressed in this assessmentSLO a)Identify and discuss the general principles of pharmacology including pharmacokinetic concepts and pharmacodynamics and theirapplication to pathophysiological states.SLO b)Explain and apply quality & safety frameworks to the use of therapeutic medicines in clinical practiceSLO c)Compare and contrast the mechanisms of action, therapeutic uses, adverse effects, interactions, contraindications and routes ofadministration of different drug groups.SLO d)Deduce the factors contributing to individual variability and determine dosage individualisation strategies to control variability in drugresponse including lifespan aspects of drug therapy and population groups with specific needs.SLO e)Identify and justify utilisation of evidence-based reference resources relating to integrative pharmacology to identify, prevent andclinically manage polypharmacy, potential adverse drug reactions, interactions and toxicity to ensure safe practices.SLO g)Explore and apply professional, legal and ethical issues surrounding the safe prescription and administration of medications.
- Assignment status: Already Solved By Our Experts
- (USA, AUS, UK & CA PhD. Writers)
- CLICK HERE TO GET A PROFESSIONAL WRITER TO WORK ON THIS PAPER AND OTHER SIMILAR PAPERS, GET A NON PLAGIARIZED PAPER FROM OUR EXPERTS
